14-3-3 Proteins and spinocerebellar ataxia type 1: From molecular interaction to human neuropathology

Cerebellum

Volumn 9, Issue 2, 2010, Pages 183-189

  Umahara, Takahiko ^a,b   Uchihara, Toshiki ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

14 3 3 Proteins; Ataxin 1; Huntington's disease; Phosphorylation; Polyglutamine disease; Spinocerebellar ataxia type 1

Indexed keywords

ATAXIN 1; HUNTINGTIN; ISOPROTEIN; POLYGLUTAMINE; PROTEIN 14 3 3; ATAXIN-1; NERVE PROTEIN; NUCLEAR PROTEIN; PEPTIDE;

BINDING AFFINITY; CELLULAR DISTRIBUTION; HUMAN; IMMUNOLOCALIZATION; MOLECULAR INTERACTION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SPINOCEREBELLAR DEGENERATION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; BRAIN; GENETICS; METABOLISM; PATHOLOGY; REVIEW;

14-3-3 PROTEINS; ANIMALS; BRAIN; HUMANS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN ISOFORMS; SPINOCEREBELLAR ATAXIAS;

EID: 77955495045     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-010-0158-9     Document Type: Short Survey

References (42)

1. Zoghbi HY, Orr HT (2001) Spinocerebellar ataxias. In: Scriver CR, Sly WS, Childs AL, Beaudet AL, Valle D, Kinzler KW et al (eds) The metabolic and molecular basis of inherited disease. McGraw professionals, New York, pp 5741-5758
2. Matilla-Dueňas A, Goold R, Giunti P (2008) Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1. Cerebellum 7:106-114
3. Koyano S, Iwabuchi K, Yagishita S, Kuroiwa Y, Uchihara T (2002) Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. J Neurol Neurosurg Psychiatry 73:450-452
4. Nagaoka U, Uchihara T, Iwabuchi K, Konno H, Tobita M, Funata N, Yagishita S, Kato T (2003) Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains. J Neurol Neurosurg Psychiatry 74:597-601
5. Qi M-L, Tagawa K, Enokida Y, Yoshimura N, Wada Y, Watase K, Ishiura S, Kanazawa I, Botas J, Saitoe M, Wanke EE, Okazawa H (2007) Proteome analysis of soluble nuclear proteins reveals the HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat Cell Biol 9:402-414
6. Vig PJ, Shao Q, Subramony SH, Lopez ME, Safaya E (2009) Bergmann glial S100B activates myo-inositol monophosphatase 1 and co-localizes to Purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum 8:231-244
7. Emamian ES, Kaytor MD, Duvic LA, Tousey SK, Zoghbi HY, Clark HB et al (2003) Serine 776 of ataxin-1 is critical for polyglutamineinduced disease in SCA 1 transgenic mice. Neuron 38:375-387
8. Chen H-K, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandes MH et al (2003) Interaction of Aktphosphorylated ataxin-1 with 14-3-3 mediates neurodegeration in spinocerebellar ataxia type. Cell 113:457-468
9. Lam YC, Bowman AB, Jafar-Najad P, Richman R, Fryer JD, Hyun ED et al (2006) ATAXIN-1 interacts with the repressor Caplcua in its native complex to cause SCA1 neuropathology. Cell 127:1335-1347
10. Lim J, Crespo-Barreto J, Jafar-Nejad P, Bowman AB, Richman R, Hill DE et al (2008) Opposing effects of polyglutamine expansion on native protein complex contribute to SCA1. Nature 452:713-718
11. Umahara T, Uchihara T, Yagishita S, Nakamura A, Tsuchiya T, Iwamoto T (2007) Intranuclear immunolocalization of 14-3-3 protein isoforms in brains with spinocerebellar ataxia type 1. Neurosci Lett 414:130-135
12. Moore BW, Perez VJ (1967) Specific acidic proteins of the nervous system. In: Carlson FD (ed) Physiological and biochemical aspects of nervous integration. Printice-Hall, New Jersey, pp 343-359
13. Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:162-172
14. Tzivion G, Avruch J (2001) 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 14:3061-3064
15. Berg D, Holzmann C, Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752-762
16. Takahashi Y (2003) The 14-3-3 proteins: gene expression, and function. Neurochem Res 28:1265-1273
17. Dougherty MK, Morrison DK (2004) Unlocking the code of 14-3-3. J Cell Sci 117:1875-1884
18. Mhawech P (2005) 14-3-3 proteins-an update. Cell Res 15:228-236
19. Zha J, Harada H, Yang H, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell 87:619-692
20. Sunayama J, Turuta F, Masuyanma N, Gotho Y (2005) JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170:295-304
21. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 protein in cerebrospinal fluid as a maker for transmissible spongiform encephalopathy. New Engl J Med 335:924-930
22. Kawamoto Y, Akiguchi I, Nakamura S, Honjyo Y, Shibasaki H, Budka H (2002) 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brain. J Neuropathol Exp Neurol 61:245-253
23. Kawamoto Y, Akiguchi I, Nakamura S, Budka H (2002) Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol 52:722-731
24. Layfield R, Fergusson J, Aitken A, Lowe J, Landon L (1996) Neurofibrillary tangles of Alzheimer's desease brain contain 14-3-3 protein. Neurosci Lett 209:57-60
25. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, Iwamoto T (2004) 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease. Acta Neuropathol 108:279-286
26. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Ikeda K, Iwamoto T (2004) Immunolocalization of 14-3-3 isoforms in brains with Pick body disease. Neurosci Lett 371:215-219
27. Toyo-oka K, Shinoyama A, Gambello MJ, Cardoso C, Leventer R, Ward HL et al (2003) 14-3-3 epsilon is important for neuronal migration by binding to NUDEL: a molecular expression for Miller-Dieker syndrome. Nat Genet 34:274-285
28. Zhang J, Popken GJ, Ye P (2003) Down-regulation of 14-3-3 eta gene expression by IGF-I in mouse cerebellum during postnatal development. Brain Res Dev Brain Res 143:199-206
29. Sato S, Ohiba T, Sakata E, Kato K, Mizuno Y, Hattori N et al (2006) 14-3-3 eta is a novel regulator of parkin ubiquitin ligase. EMBO J 25:211-221
30. Umahara T, Uchihara T, Nakamura A, Tsuchiya T, Iwamoto T (2009) Isoform-dependent immunolocalization of 14-3-3 proteins in developing rat cerebellum. Brain Res 1253:15-26
31. Steinacker P, Schwarz P, Rein K, Brechlin P, Jahn O, Kratzin H et al (2005) Unchanged survival rats of 14-3-3 gamma knockout mice after inoculation with pathological prion protein. Mol Biol Cell 25:1339-1346
32. Baxter HC, Liu WG, Forster JL (2002) Immunolocalization of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience 109:5-14
33. Umahara T, Uchihara T, Nakamura A, Tsuchiya T, Iwamoto T (2007) Intranuclear localization and isoform-dependent translocation of 14-3-3 proteins in human brain with infarction. J Neurol Sci 260:159-166
34. Jorgensen ND, Andresen JM, Lagalwar S, Armstrong B, Stevens S, Byam CE et al (2009) Phosphorylation of ATXN1 at Ser776 in the cerebellum. J Neurochem 110:675-686
35. Heintz N (2003) Ataxin-1 regulators in the spotlight. Science 301:59-60
36. Waelter A, Boeddrich R, Lurz E, Scherzinger G, Lueder H, Lehrach EE et al (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 12:1393-1407
37. Omi K, Hachiya NS, Tanaka M, Tokunaga K, Kaneko K (2008) 14-3-3zeta is indispensable for aggregate formation of polyglutamineexpanded huntingtin protein. Neurosci Lett 24:45-50
38. Wang Y, Meriin AB, Zaarur N, Romanova NV, Cheroff YO, Costello CE, Sherman MY (2009) Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 23:451-463
39. Rong J, Shihua Li, Sheng G, Wu M, Coblitz B, Li M et al (2007) 14-3-3 protein interacts with huntingtin-associated protein 1 and regulates its trafficking. J Bio Chem 280:4748-4756
40. Uchihara T, Paulus W (2008) Research into neurodegenerative disease: an entangled web of mice and men. Acta Neuropathol 115:1-4
41. Grozinger CM, Schreiber SL (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Ntnl Acad Sci USA 97:7835-7840
42. Pan S, Sehnke PS, Ferl RJ, Gurley WB (1999) Specific interactions with TBP and TFIIB in vitro suggest that 14-3-3 proteins may participate in the regulation of transcription when part of a DNA binding complex. Plant Cell 11:1591-1602